Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107,809,066
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
61,851,171
-
Shares change
-
+3,387,499
-
Total reported value, excl. options
-
$3,364,841,363
-
Value change
-
+$187,799,640
-
Put/Call ratio
-
518%
-
Number of buys
-
143
-
Number of sells
-
65
-
Price
-
$54.40
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q4 2020
As of 31 Dec 2020 Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) had 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,851,171 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, CHEVY CHASE TRUST HOLDINGS, INC., Atlas Venture Associates IX, LLC, and Atlas Venture Associates IX, LLC.
This table shows 239 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.